Silicon Labs cuts FY2025 operating loss to USD 36.9 million, down 68%

Reuters
02/11
Silicon Labs cuts FY2025 operating loss to USD 36.9 million, down 68%

Silicon Labs reported its earnings for the fiscal year ending January 3, 2025, with revenues increasing by USD 200.4 million compared to the prior year, driven by higher sales in both its Industrial & Commercial products and Home & Life products segments. Gross margin rose to 58.2% for the full year, up from 53.4% in the previous fiscal year, primarily due to lower indirect and overhead expenses. The company noted that 91% of its revenues for the period were derived from customers outside the United States. Arrow Electronics and Edom Technology accounted for 28% and 21% of total revenues, respectively, during the period. Silicon Labs highlighted that its product demand continues to be subject to some seasonal factors, especially for consumer-related ICs, but rapid market changes make the impact of seasonality difficult to estimate. The period also saw a focus on managing research and development costs relative to the commercial success of new products. Interest income, interest expense, and tax provision figures were also included, reflecting ongoing management of cash balances and financing obligations.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Silicon Laboratories Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001038074-26-000005), on February 10, 2026, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10